Lifastuzumab (Anti-SLC34A2)

Lifastuzumab (Anti-SLC34A2) is a monoclonal antibody targeting SLC34A2 (sodium phosphate 2 transporter(NaPi2b)). It has anticancer activity and can be used in research of ovarian cancer (OC).

Price Not Available 1mg*5 Lifastuzumab (Anti-SLC34A2) Supplier Page
Trivial name NaPi3b
Catalog Number A3163
CAS# 1615697-16-9
Size 1mg*5